glp 1 agonists list GLP-1 Receptor GLP-1 Agonists: A Comprehensive Overview

The company noted the candidate's competitive safety profile and sustained efficacy over 28 weeks, with plans to advance it into Phase 3 trials in 2026

JAMA 2019;321:146680.PubMedPMC 24

In patients on basal insulin who require additional prandial control, GLP-1RAs are again positioned ahead of DPP-4 inhibitors in the AACE algorithm 51

However, from our previous study [34] we clearly saw that to detect the feeding regulation effects that we described, using only Vehicle control data in the present study would not necessarily provide enough statistical power in the small sample size setting necessitated by the use of non-human primates